Latest Breaking News On - New patent covering - Page 1 : comparemela.com

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Davidh-crean
Kazuko-matsuda
Nasdaq
Uveal-melanoma-in-molecular-cancer-research
Medicinova-inc
Exchange-commission
Trademark-office
Nova-receives-notice
New-patent-covering
Standard-market

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Davidh-crean
Kazuko-matsuda
Trademark-office
Medicinova-inc
Nasdaq
Exchange-commission
Nova-receives-notice
New-patent-covering
Chlorine-induced-acute-respiratory-distress
Standard-market

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Japan
China
Tokyo
Kazuko-matsuda
Geoff-obrien
Exchange-commission
Medicinova-inc
Japan-patent-office
Nasdaq
Nova-receives
New-patent-covering
Macular-injury

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Geoff-obrien
Kazuko-matsuda
Medicinova-inc
Trademark-office
Nasdaq
Exchange-commission
European-patent-office
Nova-receives
New-patent-covering
Standard-market

MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada

MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Canada
Canadian
Geoff-obrien
Kazuko-matsuda
Canadian-intellectual-property-office
Nasdaq
Exchange-commission
European-commission
Medicinova-inc
Nova-receives